AUPS317302A0 - Metastable pharmaceutical compositions - Google Patents

Metastable pharmaceutical compositions

Info

Publication number
AUPS317302A0
AUPS317302A0 AUPS3173A AUPS317302A AUPS317302A0 AU PS317302 A0 AUPS317302 A0 AU PS317302A0 AU PS3173 A AUPS3173 A AU PS3173A AU PS317302 A AUPS317302 A AU PS317302A AU PS317302 A0 AUPS317302 A0 AU PS317302A0
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
metastable
metastable pharmaceutical
compositions
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPS3173A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Drug Delivery Solutions Pty Ltd
Original Assignee
Drug Delivery Solutions Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drug Delivery Solutions Pty Ltd filed Critical Drug Delivery Solutions Pty Ltd
Priority to AUPS3173A priority Critical patent/AUPS317302A0/en
Publication of AUPS317302A0 publication Critical patent/AUPS317302A0/en
Priority to JP2004514438A priority patent/JP2005534670A/en
Priority to PCT/AU2003/000785 priority patent/WO2004000361A1/en
Priority to NZ537436A priority patent/NZ537436A/en
Priority to AU2003240299A priority patent/AU2003240299B2/en
Priority to EA200500083A priority patent/EA012648B1/en
Priority to EP03729714A priority patent/EP1531867A4/en
Priority to KR1020047020966A priority patent/KR20050120726A/en
Priority to CA002490057A priority patent/CA2490057A1/en
Priority to BR0312003-1A priority patent/BR0312003A/en
Priority to US11/019,542 priority patent/US20050181032A1/en
Priority to JP2010172167A priority patent/JP2010248250A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015Drug-containing film-forming compositions, e.g. spray-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
AUPS3173A 2002-06-25 2002-06-25 Metastable pharmaceutical compositions Abandoned AUPS317302A0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
AUPS3173A AUPS317302A0 (en) 2002-06-25 2002-06-25 Metastable pharmaceutical compositions
BR0312003-1A BR0312003A (en) 2002-06-25 2003-06-24 Metastable pharmaceutical compositions for transdermal delivery and their uses
AU2003240299A AU2003240299B2 (en) 2002-06-25 2003-06-24 Metastable pharmaceutical compositions
PCT/AU2003/000785 WO2004000361A1 (en) 2002-06-25 2003-06-24 Metastable pharmaceutical compositions
NZ537436A NZ537436A (en) 2002-06-25 2003-06-24 Metastable pharmaceutical compositions
JP2004514438A JP2005534670A (en) 2002-06-25 2003-06-24 Metastable pharmaceutical composition
EA200500083A EA012648B1 (en) 2002-06-25 2003-06-24 Pharmaceutical composition for transdermal active agent delivery (variants)
EP03729714A EP1531867A4 (en) 2002-06-25 2003-06-24 Metastable pharmaceutical compositions
KR1020047020966A KR20050120726A (en) 2002-06-25 2003-06-24 Metastable pharmaceutical compositions
CA002490057A CA2490057A1 (en) 2002-06-25 2003-06-24 Metastable pharmaceutical compositions
US11/019,542 US20050181032A1 (en) 2002-06-25 2004-12-23 Metastable pharmaceutical compositions
JP2010172167A JP2010248250A (en) 2002-06-25 2010-07-30 Metastable pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPS3173A AUPS317302A0 (en) 2002-06-25 2002-06-25 Metastable pharmaceutical compositions

Publications (1)

Publication Number Publication Date
AUPS317302A0 true AUPS317302A0 (en) 2002-07-18

Family

ID=3836732

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPS3173A Abandoned AUPS317302A0 (en) 2002-06-25 2002-06-25 Metastable pharmaceutical compositions

Country Status (9)

Country Link
EP (1) EP1531867A4 (en)
JP (2) JP2005534670A (en)
KR (1) KR20050120726A (en)
AU (1) AUPS317302A0 (en)
BR (1) BR0312003A (en)
CA (1) CA2490057A1 (en)
EA (1) EA012648B1 (en)
NZ (1) NZ537436A (en)
WO (1) WO2004000361A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013024084A2 (en) 2011-03-22 2016-12-06 Population Council Inc methods for remyelination of a patient, and for treating multiple sclerosis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0794378B2 (en) * 1989-08-18 1995-10-11 久光製薬株式会社 Aerosol
JPH0383924A (en) * 1989-08-28 1991-04-09 Kanebo Ltd Composition for percutaneous administration
JP2974081B2 (en) * 1990-07-26 1999-11-08 小池化学株式会社 Aerosol composition for human body
WO1992006675A1 (en) * 1990-10-18 1992-04-30 Minnesota Mining And Manufacturing Company Aerosol formulation comprising beclomethasone 17,21 dipropionate
CA2101496A1 (en) * 1992-07-31 1994-02-01 Masao Kobayashi Base for transdermal administration
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
DE19616539A1 (en) * 1996-04-25 1997-11-06 Luitpold Pharma Gmbh Alcoholic solutions containing acetylsalicylic acid for percutaneous use, their use for antithrombotic therapy and medicines
US5968919A (en) * 1997-10-16 1999-10-19 Macrochem Corporation Hormone replacement therapy drug formulations for topical application to the skin
DE60006069T2 (en) * 1999-02-05 2004-07-29 Cipla Ltd. TOPICAL SPRAYS CONTAINING A FILM-FORMING COMPOSITION
US6368618B1 (en) * 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
AU2001286995B2 (en) * 2000-08-30 2006-11-30 Besins Healthcare Luxembourg Sarl Method for treating erectile dysfunction and increasing libido in men
JP2004507511A (en) * 2000-08-30 2004-03-11 ユニメッド・ファーマシューティカルズ・インコーポレーテッド Methods for increasing testosterone and related steroid levels in women

Also Published As

Publication number Publication date
EA012648B1 (en) 2009-12-30
EA200500083A1 (en) 2005-08-25
JP2010248250A (en) 2010-11-04
CA2490057A1 (en) 2003-12-31
WO2004000361A1 (en) 2003-12-31
KR20050120726A (en) 2005-12-23
EP1531867A1 (en) 2005-05-25
BR0312003A (en) 2005-03-22
EP1531867A4 (en) 2011-03-23
NZ537436A (en) 2007-01-26
JP2005534670A (en) 2005-11-17

Similar Documents

Publication Publication Date Title
GB2389530B (en) Pharmaceutical compositions
AU2003291103A1 (en) Pharmaceutical composition
AU2003302603A1 (en) Improved opioid pharmaceutical compositions
EP1425019A4 (en) Pharmaceutical composition
GB2391473B (en) Pharmaceutical compositions
AU2003276549A1 (en) Pharmaceutical compositions containing a biguanide-glitazone combination
AU2003250372A1 (en) Pharmaceutical composition
AU2002302147A1 (en) Pharmaceutical composition
AU2003269904A1 (en) Antigen-polymer compositions
GB0213481D0 (en) Pharmaceutical compositions
AU2003284460A1 (en) Medicinal composition
AU2003216503A1 (en) Stable pharmaceutical compositions
AU2003280799A1 (en) Medicinal composition
AU2003208841A1 (en) Gasolinen compositions
AU2003280678A1 (en) Medicinal composition
AUPS317302A0 (en) Metastable pharmaceutical compositions
PL370907A1 (en) Pharmaceutical compositions
AU2003216382A1 (en) Idothyronine compositions
AUPR529701A0 (en) Pharmaceutical composition
AUPS188302A0 (en) Pharmaceutical composition
AU2003218497A1 (en) FACTORVIIa COMPOSITIONS
AU2002335161A1 (en) Medicinal composition
AUPS167102A0 (en) Pharmaceutical composition
AUPS124202A0 (en) Pharmaceutical composition
AU2002100921A4 (en) Pharmaceutical composition